Breaking News

Bioserv Appoints Pharma Technologies SVP

April 21, 2014

Schrier brings 25 years of analytical and development experience

Jay Schrier, Ph.D., has been appointed senior vice president of Pharmaceutical Technologies at Bioserv Corp.

Dr. Schrier has more than 25 years of analytical and pharmaceutical development experience and has helped create numerous cGMP-compliant analytical and pharmaceutical development departments within the pharma industry. Prior to joining the company, he was senior director of pharmaceutical development at Pacira Pharmaceuticals.

Al Hansen, chairman and chief executive officer of Bioserv Corp. and managing partner at KESA Partners, said, “We are excited to welcome someone with Dr. Schrier’s outstanding qualifications and leadership skills to our growing executive team at Bioserv. His development expertise will result in significant value creation for our manufacturing clients. Dr. Schrier will provide expertise to our clients to enable them to manufacture their products to high quality standards but in a cost-effective manner.”

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks